Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06584773 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients

Name: Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients — clinical trial record (NCT06584773)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: QIS

StatusUnknown

PhasePhase 4

SponsorUniversity of Sao Paulo General Hospital

Started2015-06

View on ClinicalTrials.gov ↗

Amendment history

2026-09-06

Trial status changed: Recruiting → Unknown

University of Sao Paulo General Hospital

109 trials monitored

See 2 trials at risk

In this study, sensitized renal transplant recipients, who present an increased risk of acute rejection, will be evaluated for the benefit of quadruple immunosuppression, adding sirolimus to the traditional scheme with tacrolimus, mycophenolate, and prednisone.

Trial Details

NCT Number	NCT06584773
Lead Sponsor	University of Sao Paulo General Hospital Collaborators: Carlucci G Ventura, Daniel R Salomon, Fabiana Agena, Flavio J de Paula, Francine B Lemos, Gislene Bezerra, Helcio Rodrigues, Maria da Luz Fernandes, Nelson Zocoler Galante, Noemia B de Lima, Paschoalina Romano, Patricia S Souza, Vivian Onuchic, Elias David Neto
Conditions	Disorder Related to Renal Transplantation
Enrollment	80 participants
Start Date	2015-06
Primary Completion	2024-08 (estimated)
Study Completion	2025-07 (estimated)
Updated on ClinicalTrials.gov	2024-09-05